Measles is one of the most contagious human infectious diseases and remains a major cause of childhood morbidity and mortality worldwide. The signaling lymphocyte activation molecule (SLAM), also called CD150, is a cellular receptor for measles virus (MV), presumably accounting for its tropism for immune cells and its immunosuppressive properties. On the other hand, pathological studies have shown that MV also infects epithelial cells at a later stage of infection, although its mechanism has so far been unknown. In this study, we show that wild-type MV can infect and produce syncytia in human polarized epithelial cell lines independently of SLAM and CD46 (a receptor for the vaccine strains of MV). Progeny viral particles are released exclusively from the apical surface of these polarized epithelial cell lines. We have also identified amino acid residues on the MV attachment protein that are likely to interact with a putative receptor on epithelial cells. All of these residues have aromatic side chains and may form a receptor-binding pocket located in a different position from the putative SLAM-and CD46-binding sites on the MV attachment protein. Thus, our results indicate that MV has an intrinsic ability to infect both polarized epithelial and immune cells by using distinctive receptorbinding sites on the attachment protein corresponding to each of their respective receptors. The ability of MV to infect polarized epithelial cells and its exclusive release from the apical surface may facilitate its efficient transmission via aerosol droplets, resulting in its highly contagious nature.
Measles remains a major cause of childhood morbidity and mortality worldwide despite the availability of efficacious vaccines. Measles virus (MV), an enveloped RNA virus belonging to the genus Morbillivirus in the family Paramyxoviridae, is transmitted via aerosol droplets and considered to be one of the most contagious human pathogens. MV has two envelope glycoproteins, the hemagglutinin (H) and fusion (F) proteins, which are responsible for receptor binding and membrane fusion, respectively (18) . MV enters a cell by membrane fusion at the cell surface. The attachment of the H protein to a cellular receptor is believed to induce the conformational change of the H protein, as well as that of the F protein, which promotes the fusion of the viral envelope with the host cell membrane. MV also causes cell-cell fusion in susceptible cells. The signaling lymphocyte activation molecule (SLAM), also known as CD150, has been identified as a receptor for MV (10, 21, 47) . SLAM is expressed on immune cells, such as activated lymphocytes, mature dendritic cells, and macrophages, providing a good explanation for the lymphotropism and immunosuppressive nature of MV (4, 51) . Although CD46, a ubiquitously expressed complement regulatory molecule, functions as a receptor for the vaccine strains of MV (8, 30) , a great majority of viruses circulating in measles patients use SLAM, but not CD46, as a receptor (35, 51) . A recent study of MV infection in macaque monkeys also identified SLAM ϩ lymphocytes and dendritic cells as the predominantly infected cell types (6) .
However, pathological data from humans and experimentally infected monkeys have shown that MV antigens and syncytia are also detected in epithelial tissues in various organs, such as the skin, oral mucosa, pharynx, trachea, esophagus, intestines, and urinary bladder (5, 24, 26, 27, 31, 33, 34, 37) . Epithelial cells do not express SLAM, and wild-type (WT) strains of MV, unlike vaccine strains, do not infect epithelial cell lines. Thus, the mechanism by which MV infects epithelial tissues remains to be determined. Recently, we have reported that a SLAM Ϫ human lung adenocarcinoma cell line, NCI-H358, supports MV entry, replication, and syncytium formation independently of SLAM and CD46 (43) . Furthermore, analyses using several monoclonal antibodies (MAbs) against the H protein indicated that the receptor-binding site on the H protein used to infect NCI-H358 cells is different from those used for SLAM and CD46 (43) .
In this study, we show that besides NCI-H358, four human polarized epithelial cell lines can support WT MV growth and syncytium formation via a SLAM-and CD46-independent mechanism.
MV is found to be released exclusively from the apical surface of these polarized cell lines. We have also identified amino acid residues on the H protein that are likely to interact with a putative receptor on epithelial cells mediating SLAM-and CD46-independent infection. These residues have aromatic side chains and may form a receptor-binding pocket strategically located on the H protein. These observations provide new insight into MV infection of epithelial cells as well as into measles pathogenesis.
MATERIALS AND METHODS

Cells.
The characteristics and culture conditions for the following cell lines used were as described previously: Vero/hSLAM (35) , B95a (25) , NCI-H157 (39), NCI-H1299 (15), A549 (16) , NCI-H460 (3), NCI-H358 (3), T84 (28), Calu-3 (12), HT29 (13), Caco-2 (12), PC-3 (23), MDCK (14) , LLC-PK1 (22) , and Vero C1008 (9) .
RESULTS
Infection of epithelial cells with WT MV.
In an attempt to understand why WT MV can grow in the NCI-H358 cell line, microarray analysis was performed to compare its gene expression pattern with the patterns of other nonsusceptible human lung carcinoma cell lines. The results showed that the NCI-H358 cells express several genes encoding molecules involved in tight-junction formation or cell adhesion at significantly higher levels than those of the nonsusceptible cell lines (data not shown). This prompted us to examine the susceptibility of several polarized epithelial cell lines to WT MV. Caco-2, HT29, T84, Calu-3, MDCK, LLC-PK1, and Vero C1008 cells are known to be "polarized cells," which form tight junctions between adjacent cells (1, 7, 9, 17, 36, 40, 49) . These cell lines showed a circumferential immunofluorescent staining pattern of ZO-1, a major component of the tight junction (40) , indicating one of their properties as polarized cells (Fig. 1A) . NCI-H358 cells also exhibited an incompletely circumferential staining pattern of ZO-1, suggesting that they may have an ability to form tight junctions. By contrast, scattered dots or short fragments of ZO-1 were observed on the surfaces or at the margins of nonpolarized cell lines (HeLa, HEK293, 293T, NCI-H460, NCI-H1299, NCI-H322, A549, NCI-H157, and (20, 44) , and observed daily. The MV-infected cells were visualized with EGFP autofluorescence. As shown previously (20, 43) , IC323-EGFP grew and produced syncytia in B95a (using SLAM as a receptor) and NCI-H358 (using an unknown receptor) cells (Fig. 1A) . The virus also grew and produced syncytia in all of the human polarized cell lines examined (Caco-2, HT29, T84, and Calu-3), disrupting tight junctions. By contrast, the polarized nonhuman cell lines (dog MDCK, porcine LLC-PK1, and monkey Vero C1008) and the nonpolarized human cell lines only rarely supported IC323-EGFP infection, and no syncytia were detected in them even when the cells were observed for 2 weeks ( Fig. 1A and data not shown). Subconfluent monolayers of these cell lines were also infected with IC323-Luci, a recombinant WT MV strain expressing the Renilla luciferase (43) . At various time intervals, the Renilla luciferase activity in cells was quantified (Fig. 1B) . In Vero/hSLAM cells (Vero cells constitutively expressing human SLAM), IC323-Luci replicated efficiently, showing the maximum luciferase activity at 45 h p.i. Although slower than that in the Vero/hSLAM cells, the luciferase activities increased in all four of the human polarized cell lines (Caco-2, HT29, T84, and Calu-3) and in the NCI-H358 cells after infection with IC323-Luci. The maximum luciferase activities in the Caco-2 and HT29 cells were as high as that in the Vero/hSLAM cells. By contrast, the luciferase activity did not increase significantly in the nonhuman polarized or human nonpolarized cell lines.
These data indicate that WT MV has an ability to grow and form syncytia in human polarized epithelial cells as well as in NCI-H358 cells.
Exclusive budding of WT MV at the apical surface of polarized cells. The confluent monolayers of the Caco-2 cells forming tight junctions were prepared on the filters of Transwell permeable supports, and 1 ϫ 10 4 CIU of IC323-EGFP was inoculated into the apical medium. After 2 h of incubation with the virus, the cells were washed with PBS and then cultured in fresh medium at 37°C. At various days p.i., the amounts of the virus in the apical and basolateral media were determined ( Fig.  2A) . At 4 days p.i., more than 1 ϫ 10 2 CIU/ml of infectious virus was detected in the apical medium. At 18 days p.i., the virus titer in the apical medium reached 6 ϫ 10 4 CIU/ml. The virus titer in the basolateral medium increased only after 24 days p.i., when tight junctions were disrupted by an MV-induced cytopathic effect. Similar data were obtained with the HT29 (Fig. 2B ) and T84 (data not shown) cells. The monolayers of the Caco-2 cells were also infected with IC323-EGFP from the basolateral side. The virus entered the cells much less efficiently than it did from the apical side, and infectious virus particles were again released mostly from the apical side (data not shown). Analyses by confocal microscopy showed that H, F, and matrix proteins were predominantly transported to the apical surface of the WT-MV-infected cells (data not shown). All these data indicate that WT MV buds almost exclusively from the apical surface of polarized epithelial cells. Identification of residues on the H protein critical for fusion of NCI-H358 cells induced by MV H and F proteins. Amino acid residues on the H protein that are important in supporting cell-cell fusion in epithelial cells induced by MV glycoproteins were examined. Our previous study suggested that WT MV uses a novel receptor-binding site on the H protein which is different from those for SLAM and CD46 to infect epithelial cells (43) . That receptor-binding site is, however, likely to overlap that for CD46, as the N481Y substitution, which enables WT MV to use CD46 as a receptor, also enhances the ability of WT MV to grow and induce syncytia in the NCI-H358 epithelial cells via a CD46-independent mechanism (43) . Asn at position 481 of the H protein (of the IC-B WT strain) was replaced with Phe, Ser, Thr, Ala, Arg, Glu, or Tyr, and the mutated H proteins were transiently expressed, together with the F protein, in B95a and NCI-H358 cells. None of the substitutions affected the cell-cell fusion of B95a cells (Fig. 3 and data not shown), consistent with the observation that the residue at position 481 is not involved in the H protein interaction with SLAM (48) . Similarly, none of the substitutions inhibited the cell-cell fusion of NCI-H358 cells, indicating that the residue at position 481 is not critical for the H protein to support cell-cell fusion of the cells (Fig. 3 and data not shown) . How- (Fig. 3) . These results suggest that aromatic residues (Tyr and Phe) at position 481 positively modulate the interaction of the H protein with the putative receptor on NCI-H358 cells. Recently, we have determined the crystal structure of the MV H protein, which allowed us to precisely locate the amino acid residues presumed to be interacting with SLAM and CD46 (19) . The structure also revealed that there are many residues on the surface of the molecule which are well conserved among different morbilliviruses and reside outside the putative SLAM-and CD46-binding sites (Fig. 4A) . We speculated that these conserved residues may be involved in SLAM-and CD46-independent infection of epithelial cells. To test this possibility, the H proteins with substitutions at these residues (Phe483, Asp521, Leu522, Tyr524, Tyr541, Tyr543, Ser544, Arg547, Ser550, and Tyr551) were examined for their ability to support the cell-cell fusion of NCI-H358 cells induced by H and F proteins. The L522A and Y524S substitutions caused the H protein to lose the ability to support cell-cell fusion in both B95a and NCI-H358 cells, whereas the D521S, S544A, R547S, and S550A substitutions exhibited little effect on the cell-cell fusion of either cell line (data not shown). The Y551S substitution inhibited the cell-cell fusion of B95a cells but not that of NCI-H358 cells (data not shown). Importantly, the F483A, Y541S, and Y543S substitutions caused the H protein to lose the ability to support syncytium formation in NCI-H358 cells but not in B95a cells (Fig. 4B) .
Infection of human epithelial cells with recombinant MV strains bearing the H protein with specific substitutions. Substitutions in the H protein that enhanced (N481Y and N481F) or suppressed (F483A and Y543S) syncytium formation in NCI-H358 cells were introduced into the genomes of infectious MVs by reverse genetics techniques (29, 41, 44) . The The conserved residues on H proteins of seven morbilliviruses (measles, rinderpest, peste-des-petits-ruminants, canine distemper, dolphin distemper, porpoise distemper, and phocine distemper viruses). The H protein monomer is illustrated as observed almost from the top. Red, identical; salmon pink, strong similarity; wheat yellow, weak similarity; gray, little similarity. The residues at the putative SLAM-binding sites are shown with asterisks, and those at the putative CD46-binding sites are denoted in italics. The underlined residues, which are conserved among morbilliviruses and reside outside the putative SLAM-and CD46-binding sites, were studied by mutagenesis. (B) NCI-H358 and B95a cells cultured in six-well-cluster plates were transfected with the WT or mutant-H-protein-expressing plasmid (1 g) together with the F-protein-expressing plasmid (1 g). At 2 (B95a) or 3 (NCI-H358) days posttransfection, cells were observed under a phase-contrast imaging microscope.
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on April 30, 2016 by guest http://jvi.asm.org/ recombinant MV with the N481Y substitution in the H protein was reported previously (38) . All of the recombinant viruses with the mutated H proteins efficiently replicated and produced syncytia in B95a cells (Fig. 5A ). The viruses with the N481Y or N481F substitution induced much larger syncytia in NCI-H358 cells than the parental virus did (Fig. 5A) , consistent with the findings obtained with plasmid-mediated fusion analysis (Fig. 3) . These mutant viruses also induced larger syncytia in the four human polarized epithelial cell lines, HT29, Calu-3, Caco-2, and T84, than the parental virus did (Fig. 5A ). On the other hand, the mutant viruses with the F483A or Y543S substitution neither grew well nor induced syncytia in NCI-H358 cells (Fig. 5A ). The strains with the F483A or Y543S substitution did not induce syncytia in HT29 and Calu-3 cells, but they did produce syncytia in Caco-2 and T84 cells (Fig. 5A) . The growth of the mutant viruses possessing the F483A or Y543S substitution in the H protein was also examined by using recombinant MVs expressing Renilla luciferase (Fig. 5B) . These mutant viruses grew in B95a cells as efficiently as the virus carrying the WT H protein. The virus possessing the Y543S substitution grew very poorly in NCI-H358, HT29, and Calu-3 cells but replicated well in Caco-2 and T84 cells. The replication of the virus with the F483A substitution was also greatly reduced in NCI-H358, HT29, Calu-3, and Caco-2 cells but less so in T84 cells. These data suggest that although the same residues on the H protein may play an important role in WT MV infection of epithelial cells, the virus-receptor interactions are somehow different among different epithelial cell lines.
Taken together, our results indicate that Phe483, Tyr541, and Tyr543 on the H protein are important for WT MV to infect NCI-H358 and polarized epithelial cell lines. The residue at position 481 is not critical, but the presence of aromatic residues at that position greatly enhances WT MV infection of epithelial cells. These four positions are indicated on the threedimensional structure of the H protein, together with putative SLAM-and CD46-binding sites (19) (Fig. 6A and B) . (The structure shown in Fig. 6 is based on the H protein of the Edmonston strain, but all indicated residues except that at position 481 are conserved between the Edmonston and WT IC-B strains.) The aromatic side chains of these residues may form a receptor-binding pocket interacting with a putative receptor allowing MV infection of epithelial cells (Fig. 6C) .
DISCUSSION
CD46 is the first identified MV receptor (8, 30) . The ubiquitous expression of CD46 had been thought to explain the findings that MV can infect various types of cells in vivo and in vitro. Then, SLAM was identified as a receptor for both the WT and vaccine strains of MV, and the use of CD46 was shown to be limited mostly to the vaccine strains of MV (47), making us rethink measles pathogenesis. From the known distribution of SLAM in the body, the first targets for MV are likely to be dendritic cells, lymphocytes, and/or macrophages in the lymphoid tissues of the respiratory tract (51) . After the initial infection of those cells, the virus enters the blood and replicates in lymphoid tissues and organs throughout the body, causing profound immunosuppression. At a later stage of infection, infected dendritic cells may transmit MV to epithelial cells (6) . Previous studies using a panel of cell lines showed that only SLAM ϩ cells support efficient WT MV infection and syncytium formation (11) . Epithelial cells do not express SLAM, and WT MV uses SLAM but not CD46 as a receptor. How then does MV infect epithelial cells in vivo? Although previous studies have shown that a low level of SLAM-independent WT MV infection occurs in various cell lines (the efficiency is 100 to 1,000 times lower than that using SLAM), this type of infection does not produce syncytia in infected cells (20) , except in primary cultures of human small-airway epithelial cells and endothelial cells (2, 46) . Here and in our previous paper (43), we have demonstrated that WT MV has the ability to infect and produce syncytia in certain epithelial cell lines. The infection is independent of SLAM and CD46. Furthermore, we have identified residues on the attachment H protein that presumably interact with the putative epithelial cell receptor. Those residues are in a location different from putative SLAM-and CD46-binding sites on the H protein. Thus, our results indicate that MV has an intrinsic ability to infect both polarized epithelial and immune cells using distinctive receptor-binding sites on the H protein corresponding to respective receptors.
All of the identified amino acid residues relevant for infection of epithelial cells are those with aromatic side chains (Phe483, Try541, and Try543), suggesting that hydrophobic interactions play an important role in the binding of the H protein to the putative receptor on epithelial cells. This is also supported by the finding that the presence of aromatic residues at position 481, which is located close to the aforementioned three positions, enhances cell-cell fusion in epithelial cells after expression of the H and F proteins or recombinant virus infection ( Fig. 3 and 5) . These results suggest that there exists a cluster of hydrophobic residues on the putative epithelial cell receptor, which interacts with the aforementioned aromatic residues on the H protein. We have previously shown that residues at the SLAM-binding site on the H protein are highly conserved among different morbilliviruses (19) . Tyr541 and Tyr543 are also highly conserved among morbilliviruses. Phe483 is found only in MV, but all other morbilliviruses have a hydrophobic Leu residue at that position. Thus, it is likely that morbilliviruses other than MV also use the same molecule as a receptor to infect epithelial cells. These relevant aromatic residues are located upward from the viral envelope (as portrayed in Fig. 6 ), because of the tilted orientation of the molecules forming the H protein dimer (19) . Thus, they should be able to interact readily with the putative receptor on epithelial cells.
Why does MV infect epithelial cells? Polarized epithelial cells form tight junctions covering the external epithelial surface. The tight junctions prevent the passage of most dissolved molecules from one side of the epithelium to the other. Thus, it is possible that MV cannot efficiently release progeny virions into the external surface through its ability to infect immune cells alone. At present, the identity of the receptor which MV uses to infect epithelial cells is unknown, but our results showed that progeny virions are selectively released into the apical side of polarized epithelial cells (the luminal side). This suggests that the ability to infect epithelial cells is necessary for MV to spread efficiently from person to person, rather than to spread only within an individual host. This may explain why human immunodeficiency virus, which shares a similar tropism for immune cells with MV, is transmitted exclusively via sexual contact or blood, whereas MV is transmitted efficiently via aerosol droplets. 
